Adverse Events Associated with Unblinded, But Not With Blinded, Statin Therapy in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm (ASCOT-LLA): A Randomised Double-Blind Placebo-Controlled Trial and Its Non-Randomised Non-Blind Extension Phase
Gupta A, Thompson D, Whitehouse A; on behalf of the ASCOT Investigators
The Lancet. Pub. online May 5, 2017
Leggi